Cargando…

Early-Onset HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis

Background: Vertical transmission of HTLV-1 could lead to the early development of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). This significantly affects quality of life and increases morbimortality. Objective: To describe the epidemiological and clinical characteristics of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schwalb, Alvaro, Pérez-Muto, Valeria, Cachay, Rodrigo, Tipismana, Martín, Álvarez, Carolina, Mejía, Fernando, González-Lagos, Elsa, Gotuzzo, Eduardo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350296/ https://www.ncbi.nlm.nih.gov/pubmed/32517313 http://dx.doi.org/10.3390/pathogens9060450

Ejemplares similares

Impact of fractures and orthopedic surgeries in patients with HTLV-1 associated myelopathy/tropical spastic paraparesis
por: Julca-Copello, Pablo, et al.
Publicado: (2020)

Changes in proviral load (PVL) among patients with rapidly progressive HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) receiving empirical therapy
por: Gotuzzo, Eduardo, et al.
Publicado: (2011)

Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2014)

Balance assessment in HTLV-1 associated myelopathy or tropical spastic paraparesis
por: Patrício, Naiane Araújo, et al.
Publicado: (2020)

IL8 Gene Polymorphism SNP rs4073 analysis between HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis and HTLV-1 Carriers
por: Rúa, Jorge, et al.
Publicado: (2015)

Three plasma biomarkers of HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul, et al.
Publicado: (2011)

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Kirk, Paul DW, et al.
Publicado: (2011)

Correction: Familial Clusters of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2016)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamakawa, Natsuko, et al.
Publicado: (2020)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

Contribution of Galvanic Vestibular Stimulation for the Diagnosis of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Matos Cunha, Luciana Cristina, et al.
Publicado: (2013)

Proposal of Classification Criteria for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Disease Activity
por: Sato, Tomoo, et al.
Publicado: (2018)

Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2017)

NFkB activation promotes immune activation in HTLV-I-associated myelopathy / tropical spastic paraparesis
por: McCormick, Matthew, et al.
Publicado: (2011)

Patterns of spinal cord atrophy in HTLV-1 associated myelopathy/ tropical spastic paraparesis (HAM/TSP)
por: Charlip, Emily, et al.
Publicado: (2015)

Novel Complications with HTLV‐1‐associated Myelopathy/Tropical Spastic Paraparesis: Interstitial Cystitis and Persistent Prostatitis
por: Nomata, Koichiro, et al.
Publicado: (1992)

Genome wide association study of HTLV-1–associated myelopathy/tropical spastic paraparesis in the Japanese population
por: Penova, Marina, et al.
Publicado: (2021)

Impaired flexibility in patients with tropical spastic paraparesis/HTLV-associated myelopathy: evaluation via pendulum fleximeter
por: Landim, Caroline, et al.
Publicado: (2023)

CD80(+) and CD86(+) B cells as biomarkers and possible therapeutic targets in HTLV-1 associated myelopathy/tropical spastic paraparesis and multiple sclerosis
por: Menezes, Soraya Maria, et al.
Publicado: (2014)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

Visualization of HTLV-1–Specific Cytotoxic T Lymphocytes in the Spinal Cords of Patients With HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Matsuura, Eiji, et al.
Publicado: (2015)

CXCL10 and neopterin in CSF are candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Yamano, Yoshihisa, et al.
Publicado: (2014)

Biomarker to predict treatment response in patients with HTLV-1 associated myelopathy/Tropical spastic paraparesis (HAM/TSP)
por: Tamaki, Keiko, et al.
Publicado: (2015)

Real-world clinical course of HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Japan
por: Tsutsumi, Shuntaro, et al.
Publicado: (2019)

Mortality and risk of progression to adult T cell leukemia/lymphoma in HTLV-1–associated myelopathy/tropical spastic paraparesis
por: Nagasaka, Misako, et al.
Publicado: (2020)

Pregnancy complicated by HTLV‐1‐associated myelopathy/tropical spastic paraparesis (HAM/TSP): a case report
por: Mori, Hiroshi, et al.
Publicado: (2021)

Editorial Commentary: Human T-Cell Lymphotropic Virus Type 1 (HTLV-1) and HTLV-1–Associated Myelopathy/Tropical Spastic Paraparesis
por: Taylor, Graham P.
Publicado: (2015)

Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Baratella, Marco, et al.
Publicado: (2017)

Human T-lymphotropic virus type 1 (HTLV-1) and cellular immune response in HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Nozuma, Satoshi, et al.
Publicado: (2020)

Ciclosporin A Proof of Concept Study in Patients with Active, Progressive HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis
por: Martin, Fabiola, et al.
Publicado: (2012)

Quantifying spinal cord cross-sectional area in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Liu, Winston, et al.
Publicado: (2014)

INTERFERON BETA-1A TREATMENT IN HTLV-1-ASSOCIATED MYELOPATHY/TROPICAL SPASTIC PARAPARESIS: A CASE REPORT
por: Viana, Graça Maria de Castro, et al.
Publicado: (2014)

Increased expression of OX40 is associated with progressive disease in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
por: Saito, Mineki, et al.
Publicado: (2013)

Clinical presentation of axial myopathy in two siblings with HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Matsuura, Eiji, et al.
Publicado: (2015)

HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Is Not Associated with SNP rs12979860 of the IL-28B Gene
por: Vallinoto, Antonio C. R., et al.
Publicado: (2015)

Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients
por: Queiroz, Gabriel Andrade Nonato, et al.
Publicado: (2019)

Cerebrospinal Fluid CXCL10 as a Candidate Surrogate Marker for HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis
por: Tamaki, Keiko, et al.
Publicado: (2019)

HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) versus adult T-cell leukemia/lymphoma (ATLL)
por: Zarei-Ghobadi, Mohadeseh, et al.
Publicado: (2021)

Clinical and laboratory features of HTLV-I asymptomatic carriers and patients with HTLV-I-associated myelopathy/tropical spastic paraparesis from the Brazilian Amazon
por: Takatani, Massanobu, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_vlo65sqduq7v66o6hvf34534v6